Comparing comparators: a look at control arms in kidney cancer studies over the years

by Bracarda, S, Porta, C, Sisani, M, Marrocolo, F, Paglino, C, Hamzaj, A, D Buono, S, Sternberg, C N
Published 2015

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

by Procopio, G, Verzoni, E, Bracarda, S, Ricci, S, Sacco, C, Ridolfi, L, Porta, C, Miceli, R, Zilembo, N, Bajetta, E
Published 2011

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

by Procopio, G, Bellmunt, J, Dutcher, J, Bracarda, S, Knox, J, Brueckner, A, Molnar, I, Escudier, B, Hutson, T E
Published 2013

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors

by Santoni, Matteo, Bracarda, Sergio, Nabissi, Massimo, Massari, Francesco, Conti, Alessandro, Bria, Emilio, Tortora, Giampaolo, Santoni, Giorgio, Cascinu, Stefano
Published 2014

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

by Bracarda, S, Hutson, T E, Porta, C, Figlin, R A, Calvo, E, Grünwald, V, Ravaud, A, Motzer, R, Kim, D, Anak, O, Panneerselvam, A, Escudier, B
Published 2012

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer

by Di Lorenzo, Giuseppe, Bracarda, Sergio, Gasparro, Donatello, Gernone, Angela, Messina, Caterina, Zagonel, Vittorina, Puglia, Livio, Bosso, Davide, Dondi, Davide, Sonpavde, Guru, Lucarelli, Giuseppe, De Placido, Sabino, Buonerba, Carlo
Published 2016

A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent

by Sharma, Padmanee, Grimm, Marc-Oliver, Galsky, Matthew D, Baron, Ari, Bracarda, Sergio, Siefker-Radtke, Arlene, Lambert, Alexandre, Azrilevich, Alex, Retz, Margitta
Published 2015

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REAC...

by Bono, Petri, Oudard, Stephane, Bodrogi, Istvan, Hutson, Thomas E., Escudier, Bernard, Machiels, Jean-Pascal, Thompson, John A., Figlin, Robert A., Ravaud, Alain, Basaran, Mert, Porta, Camillo, Bracarda, Sergio, Brechenmacher, Thomas, Lin, Chinjune, Voi, Maurizio, Grunwald, Viktor, Motzer, Robert J.
Published 2016

Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey

by Santini, Daniele, Procopio, Giuseppe, Porta, Camillo, Ibrahim, Toni, Barni, Sandro, Mazzara, Calogero, Fontana, Andrea, Berruti, Alfredo, Berardi, Rossana, Vincenzi, Bruno, Ortega, Cinzia, Ottaviani, Davide, Carteni, Giacomo, Lanzetta, Gaetano, Virzì, Vladimir, Santoni, Matteo, Silvestris, Nicola, Satolli, Maria Antonietta, Collovà, Elena, Russo, Antonio, Badalamenti, Giuseppe, Fedeli, Stefano Luzi, Tanca, Francesca Maria, Adamo, Vincenzo, Maiello, Evaristo, Sabbatini, Roberto, Felici, Alessandra, Cinieri, Saverio, Tonini, Giuseppe, Bracarda, Sergio
Published 2013

Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study

by Angelo Porreca, Marianna Noale, Walter Artibani, Pier Francesco Bassi, Filippo Bertoni, Sergio Bracarda, Giario Natale Conti, Renzo Corvò, Mauro Gacci, Pierpaolo Graziotti, Stefano Maria Magrini, Vincenzo Mirone, Rodolfo Montironi, Giovanni Muto, Stefano Pecoraro, Umberto Ricardi, Elvio Russi, Andrea Tubaro, Vittorina Zagonel, Gaetano Crepaldi, Stefania Maggi, the Pros-IT CNR study group
Published 2018-06-01

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

by Gore, M E, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, G A, Oudard, S, Lee, S-H, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, R E, Crinò, L, Kim, T M, Carteni, G, Eberhardt, W E E, Zhang, K, Fly, K, Matczak, E, Lechuga, M J, Hariharan, S, Bukowski, R
Published 2015

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

by Santoni, Matteo, Conti, Alessandro, Procopio, Giuseppe, Porta, Camillo, Ibrahim, Toni, Barni, Sandro, Guida, Francesco Maria, Fontana, Andrea, Berruti, Alfredo, Berardi, Rossana, Massari, Francesco, Vincenzi, Bruno, Ortega, Cinzia, Ottaviani, Davide, Carteni, Giacomo, Lanzetta, Gaetano, De Lisi, Delia, Silvestris, Nicola, Satolli, Maria Antonietta, Collovà, Elena, Russo, Antonio, Badalamenti, Giuseppe, Luzi Fedeli, Stefano, Tanca, Francesca Maria, Adamo, Vincenzo, Maiello, Evaristo, Sabbatini, Roberto, Felici, Alessandra, Cinieri, Saverio, Montironi, Rodolfo, Bracarda, Sergio, Tonini, Giuseppe, Cascinu, Stefano, Santini, Daniele
Published 2015